TNF-alpha and TLR Agonists Increase Susceptibility to HIV-1 Transmission by Human Langerhans Cells Ex Vivo

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2008 Sep 9

PMID 18776939

Citations 68

Authors

Marein A W P de Jong

Lot de Witte

Menno J Oudhoff

Sonja I Gringhuis

Philippe Gallay

Teunis B H Geijtenbeek

Affiliations

Soon will be listed here.

Abstract

Genital coinfections increase an individual's risk of becoming infected with HIV-1 by sexual contact. Several mechanisms have been proposed to explain this, such as the presence of ulceration and bleeding caused by the coinfecting pathogen. Here we demonstrate that Langerhans cells (LCs) are involved in the increased susceptibility to HIV-1 in the presence of genital coinfections. Although LCs are a target for HIV-1 infection in genital tissues, we found that immature LCs did not efficiently mediate HIV-1 transmission in an ex vivo human skin explant model. However, the inflammatory stimuli TNF-alpha and Pam3CysSerLys4 (Pam3CSK4), the ligand for the TLR1/TLR2 heterodimer, strongly increased HIV-1 transmission by LCs through distinct mechanisms. TNF-alpha enhanced transmission by increasing HIV-1 replication in LCs, whereas Pam3CSK4 acted by increasing LC capture of HIV-1 and subsequent trans-infection of T cells. Genital infections such as Candida albicans and Neisseria gonorrhea not only triggered TLRs but also induced TNF-alpha production in vaginal and skin explants. Thus, during coinfection, LCs could be directly activated by pathogenic structures and indirectly activated by inflammatory factors, thereby increasing the risk of acquiring HIV-1. Our data demonstrate a decisive role for LCs in HIV-1 transmission during genital coinfections and suggest antiinflammatory therapies as potential strategies to prevent HIV-1 transmission.

Citing Articles

The spatial biology of HIV infection.

Hu K, ONeil T, Baharlou H, Austin P, Karrasch J, Sarkawt L PLoS Pathog. 2025; 21(1):e1012888.

PMID: 39854613 PMC: 11760614. DOI: 10.1371/journal.ppat.1012888.

Risk factors for viral hepatitis in pulmonary tuberculosis patients undergoing treatment: A systematic review and meta-analysis.

Ilham A, Andini S, Afladhia H, Rakasiwi M, Burhan E Narra J. 2025; 4(3):e1242.

PMID: 39816129 PMC: 11731815. DOI: 10.52225/narra.v4i3.1242.

Prevotella timonensis Bacteria Associated With Vaginal Dysbiosis Enhance Human Immunodeficiency Virus Type 1 Susceptibility Of Vaginal CD4+ T Cells.

van Teijlingen N, van Smoorenburg M, Sarrami-Forooshani R, Zijlstra-Willems E, van Hamme J, Borgdorff H J Infect Dis. 2024; 230(1):e43-e47.

PMID: 39052703 PMC: 11272099. DOI: 10.1093/infdis/jiae166.

Immune activation of vaginal human Langerhans cells increases susceptibility to HIV-1 infection.

van Teijlingen N, Eder J, Sarrami-Forooshani R, Zijlstra-Willems E, Roovers J, van Leeuwen E Sci Rep. 2023; 13(1):3283.

PMID: 36841916 PMC: 9968315. DOI: 10.1038/s41598-023-30097-x.

Vaginal bacterium Prevotella timonensis turns protective Langerhans cells into HIV-1 reservoirs for virus dissemination.

van Teijlingen N, Helgers L, Sarrami-Forooshani R, Zijlstra-Willems E, van Hamme J, Segui-Perez C EMBO J. 2022; 41(19):e110629.

PMID: 35968812 PMC: 9531304. DOI: 10.15252/embj.2022110629.

References

Hoffmann P, Heinle S, Schade U, Loppnow H, Ulmer A, Flad H . Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. Immunobiology. 1988; 177(2):158-70. DOI: 10.1016/S0171-2985(88)80036-6. View

Turville S, Santos J, Frank I, Cameron P, Wilkinson J, Miranda-Saksena M . Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood. 2003; 103(6):2170-9. DOI: 10.1182/blood-2003-09-3129. View

Fahrbach K, Barry S, Ayehunie S, Lamore S, Klausner M, Hope T . Activated CD34-derived Langerhans cells mediate transinfection with human immunodeficiency virus. J Virol. 2007; 81(13):6858-68. PMC: 1933306. DOI: 10.1128/JVI.02472-06. View

Ozinsky A, Underhill D, Fontenot J, Hajjar A, Smith K, Wilson C . The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci U S A. 2000; 97(25):13766-71. PMC: 17650. DOI: 10.1073/pnas.250476497. View

Romani L, Bistoni F, Puccetti P . Fungi, dendritic cells and receptors: a host perspective of fungal virulence. Trends Microbiol. 2002; 10(11):508-14. DOI: 10.1016/s0966-842x(02)02460-5. View

Arrighi J, Pion M, Garcia E, Escola J, van Kooyk Y, Geijtenbeek T . DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J Exp Med. 2004; 200(10):1279-88. PMC: 2211914. DOI: 10.1084/jem.20041356. View

Naarding M, Ludwig I, Groot F, Berkhout B, Geijtenbeek T, Pollakis G . Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes. J Clin Invest. 2005; 115(11):3256-64. PMC: 1257537. DOI: 10.1172/JCI25105. View

Spira A, Marx P, Patterson B, Mahoney J, Koup R, Wolinsky S . Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med. 1996; 183(1):215-25. PMC: 2192425. DOI: 10.1084/jem.183.1.215. View

Chatterji U, Bobardt M, Stanfield R, Ptak R, Pallansch L, Ward P . Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in Owl monkey cells. J Biol Chem. 2005; 280(48):40293-300. DOI: 10.1074/jbc.M506314200. View

10.

Sheffield J, Wendel Jr G, Mcintire D, Norgard M . Effect of genital ulcer disease on HIV-1 coreceptor expression in the female genital tract. J Infect Dis. 2007; 196(10):1509-16. DOI: 10.1086/522518. View

11.

Cohen M . HIV and sexually transmitted diseases: lethal synergy. Top HIV Med. 2004; 12(4):104-7. View

12.

Garcia-Vallejo J, van het Hof B, Robben J, van Wijk J, van Die I, Joziasse D . Approach for defining endogenous reference genes in gene expression experiments. Anal Biochem. 2004; 329(2):293-9. DOI: 10.1016/j.ab.2004.02.037. View

13.

Kawamura T, Qualbani M, Thomas E, Orenstein J, Blauvelt A . Low levels of productive HIV infection in Langerhans cell-like dendritic cells differentiated in the presence of TGF-beta1 and increased viral replication with CD40 ligand-induced maturation. Eur J Immunol. 2001; 31(2):360-8. DOI: 10.1002/1521-4141(200102)31:2<360::aid-immu360>3.0.co;2-x. View

14.

Kawamura T, Bruse S, Abraha A, Sugaya M, Hartley O, Offord R . PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes. J Virol. 2004; 78(14):7602-9. PMC: 434074. DOI: 10.1128/JVI.78.14.7602-7609.2004. View

15.

Lynch G, Slaytor E, ELLIOTT F, Saurajen A, Turville S, Sloane A . CD4 is expressed by epidermal Langerhans' cells predominantly as covalent dimers. Exp Dermatol. 2004; 12(5):700-11. DOI: 10.1034/j.1600-0625.2003.00078.x. View

16.

Underhill D . Toll-like receptors and microbes take aim at each other. Curr Opin Immunol. 2004; 16(4):483-7. DOI: 10.1016/j.coi.2004.05.012. View

17.

Matsuyama T, Yoshiyama H, Hamamoto Y, Yamamoto N, Soma G, Mizuno D . Enhancement of HIV replication and giant cell formation by tumor necrosis factor. AIDS Res Hum Retroviruses. 1989; 5(2):139-46. DOI: 10.1089/aid.1989.5.139. View

18.

Hester R, Kennedy S . Candida infection as a risk factor for HIV transmission. J Womens Health (Larchmt). 2003; 12(5):487-94. DOI: 10.1089/154099903766651612. View

19.

Takeda K, Kaisho T, Akira S . Toll-like receptors. Annu Rev Immunol. 2003; 21:335-76. DOI: 10.1146/annurev.immunol.21.120601.141126. View

20.

Wei X, Decker J, Liu H, Zhang Z, Arani R, Michael Kilby J . Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother. 2002; 46(6):1896-905. PMC: 127242. DOI: 10.1128/AAC.46.6.1896-1905.2002. View